The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Patrick M. L. Vanderheyden

Department of Molecular and Biochemical Pharmacology

Vrije Universiteit Brussel

Brussels

Belgium

[email]@vub.ac.be

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium. 2006 - 2009
  • Department of Protein Chemistry, Free University of Brussels (VUB), Sint-Genesius Rode, Belgium. 1998 - 2000
  • Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels, Sint-Genesius Rode, Belgium. 2000

References

  1. From angiotensin IV binding site to AT4 receptor. Vanderheyden, P.M. Mol. Cell. Endocrinol. (2009) [Pubmed]
  2. Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelators. Vanderheyden, P.M., Demaegdt, H., Swales, J., Lenaerts, P.J., De Backer, J.P., Vogel, L.K., Vauquelin, G. Fundam. Clin. Pharmacol (2006) [Pubmed]
  3. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors. Vanderheyden, P.M., Fierens, F.L., De Backer, J., Vauquelin, G. Biochem. Pharmacol. (2000) [Pubmed]
  4. Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?. Vanderheyden, P.M., Fierens, F.L., Vauquelin, G. Biochem. Pharmacol. (2000) [Pubmed]
  5. Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors. Vanderheyden, P.M., Verheijen, I., Fierens, F.L., DeBacker, J.P., Vauquelin, G. Pharm. Res. (2000) [Pubmed]
  6. Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptors. Vanderheyden, P.M., Verheijen, I., Fierens, F.L., Backer, J.P., Vauquelin, G. J. Renin. Angiotensin. Aldosterone. Syst (2000) [Pubmed]
  7. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors. Vanderheyden, P.M., Fierens, F.L., De Backer, J.P., Fraeyman, N., Vauquelin, G. Br. J. Pharmacol. (1999) [Pubmed]
  8. Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells. Vanderheyden, P.M., Van Liefde, I., DeBacker, J.P., Ebinger, G., Vauquelin, G. Regul. Pept. (1998) [Pubmed]
 
WikiGenes - Universities